HCP - Bausch + Lomb

John Jacob “J.J.” Bausch opens an optical goods store in Rochester, N.Y., borrowing $62 from his friend, Henry Lomb to expand the business

Bausch + Lomb begins producing its first microscopes for research use

Henry Lomb co-founds the Mechanics Institute to train skilled workers; In 1944, the name of the college is changed to the Rochester Institute of Technology, which it is still known as today

John Jacob “J.J.” Bausch opens an optical goods store in Rochester, N.Y., borrowing $62 from his friend, Henry Lomb to expand the business

Bausch + Lomb begins producing its first microscopes for research use

Henry Lomb co-founds the Mechanics Institute to train skilled workers; In 1944, the name of the college is changed to the Rochester Institute of Technology, which it is still known as today

Snapshot photography is made possible by Edward Bausch

Bausch + Lomb creates its first photographic lens

Bausch + Lomb introduces the Balopticon slide projector to project images

Used for the first time in movie houses, the Super Cinephor lens quickly becomes standard, making Bausch + Lomb a leading provider of professional lenses for the film industry

Snapshot photography is made possible by Edward Bausch

Bausch + Lomb creates its first photographic lens

Bausch + Lomb introduces the Balopticon slide projector to project images

Used for the first time in movie houses, the Super Cinephor lens quickly becomes standard, making Bausch + Lomb a leading provider of professional lenses for the film industry

Bausch + Lomb manufactures the “Ray-Ban” Aviator, a revolutionary anti-glare sunglass designed for military pilots

Bausch + Lomb develops the first ultraviolet microscope optics used for cancer research

Bausch + Lomb introduces the Cinemascope lens technology

Bausch + Lomb manufactures the “Ray-Ban” Aviator, a revolutionary anti-glare sunglass designed for military pilots

Bausch + Lomb develops the first ultraviolet microscope optics used for cancer research

Bausch + Lomb introduces the Cinemascope lens technology

Bausch + Lomb receives honorary award from the Academy of Motion Picture Arts and Sciences for advancement of the motion picture industry

A Bausch + Lomb Super Baltar lens captures the first close range images of the surface of the moon, taken from within the moon’s orbit

Bausch + Lomb launches SoftLens^® the world’s first mass-produced soft contact lenses which arethe first to be sold in the United States

Bausch + Lomb creates its first bifocal soft contact lens

Bausch + Lomb receives honorary award from the Academy of Motion Picture Arts and Sciences for advancement of the motion picture industry

A Bausch + Lomb Super Baltar lens captures the first close range images of the surface of the moon, taken from within the moon’s orbit

Bausch + Lomb launches SoftLens^® the world’s first mass-produced soft contact lenses which arethe first to be sold in the United States

Bausch + Lomb creates its first bifocal soft contact lens

Bausch + Lomb launches ReNu^® multi-action disinfection solution as one of the first contact lens cleaning products

Bausch + Lomb expands into ophthalmic pharmaceuticals by acquiring Muro Pharmaceuticals

Bausch + Lomb establishes its surgical business unit with the acquisition of Storz^® Ophthalmicand Chiron Vision

Bausch + Lomb launches ReNu^® multi-action disinfection solution as one of the first contact lens cleaning products

Bausch + Lomb expands into ophthalmic pharmaceuticals by acquiring Muro Pharmaceuticals

Bausch + Lomb establishes its surgical business unit with the acquisition of Storz^® Ophthalmicand Chiron Vision

The FDA approves Retisert^® (fluocinolone acetonide intravitreal implant) 0.59 mg as an orphan drug

Bausch + Lomb receives Health Canada approval for PureVision^® and PureVision^® Toric contact lenses

The FDA approves Retisert^® (fluocinolone acetonide intravitreal implant) 0.59 mg as an orphan drug

Bausch + Lomb receives Health Canada approval for PureVision^® and PureVision^® Toric contact lenses

Bausch + Lomb launches the Stellaris^® vision enhancement system, breaking new ground in cataract surgery

Bausch + Lomb launches Alrex^® (loteprednol etabonate ophthalmic suspension) and LOTEMAX^® (loteprednol etabonate ophthalmic suspension) 0.5%

Health Canada approves PureVision® Multifocal and PureVision^®2 contact lenses

Bausch + Lomb receives Health Canada approval for Crystalens^® intraocular lens

Bausch + Lomb launches the Stellaris^® vision enhancement system, breaking new ground in cataract surgery

Bausch + Lomb launches Alrex^® (loteprednol etabonate ophthalmic suspension) and LOTEMAX^® (loteprednol etabonate ophthalmic suspension) 0.5%

Health Canada approves PureVision® Multifocal and PureVision^®2 contact lenses

Bausch + Lomb receives Health Canada approval for Crystalens^® intraocular lens

Bausch + Lomb receives Health Canada approval for Besivance^® (besifloxacin ophthalmic suspension) 0.6% and Retisert^® (fluocinolone acetonide intravitreal implant) 0.59 mg

Bausch + Lomb receives Health Canada approval for enVista^®, the only glistening-free intraocular lens on the market

Bausch + Lomb and Technolas Perfect Vision receive Health Canada approval of the VICTUS^® femtosecond laser platform

Bausch + Lomb Canada’s commitment to overall eye health continues with Ocuvite^® and PreserVision^® eye vitamins and mineral supplements

Bausch + Lomb receives Health Canada approval for Biotrue^® multi-purpose contact lens solution for disinfecting soft contact lenses, as well as Biotrue^® ONEday daily disposable lenses

Bausch + Lomb receives Health Canada approval for PureVision^®2 for Astigmatism contact lenses and PureVision^®2 for Presbyopia contact lenses

Bausch + Lomb receives Health Canada approval for Besivance^® (besifloxacin ophthalmic suspension) 0.6% and Retisert^® (fluocinolone acetonide intravitreal implant) 0.59 mg

Bausch + Lomb receives Health Canada approval for enVista^®, the only glistening-free intraocular lens on the market

Bausch + Lomb and Technolas Perfect Vision receive Health Canada approval of the VICTUS^® femtosecond laser platform

Bausch + Lomb Canada’s commitment to overall eye health continues with Ocuvite^® and PreserVision^® eye vitamins and mineral supplements

Bausch + Lomb receives Health Canada approval for Biotrue^® multi-purpose contact lens solution for disinfecting soft contact lenses, as well as Biotrue^® ONEday daily disposable lenses

Bausch + Lomb receives Health Canada approval for PureVision^®2 for Astigmatism contact lenses and PureVision^®2 for Presbyopia contact lenses

Bausch + Lomb introduces Bausch + Lomb ULTRA^® contact lenses with MoistureSeal^® technology

Bausch + Lomb acquires Synergetics^® expanding its surgical vitreoretinal product portfolio

Bausch + Lomb receives Health Canada approval for Lotemax® (loteprednol etabonate ophthalmic ointment) 0.5%, Lotemax^® (loteprednol etabonate ophthalmic gel) 0.38% and Prolensa^® (bromfenac ophthalmic solution) 0.07%

The company expands the enVista^® family of intraocular lenses with the addition of the enVista^® Toric

Bausch + Lomb acquires Croma and launches EyeCee One preloaded IOL

Bausch + Lomb introduces Bausch + Lomb ULTRA^® contact lenses with MoistureSeal^® technology

Bausch + Lomb acquires Synergetics^® expanding its surgical vitreoretinal product portfolio

Bausch + Lomb receives Health Canada approval for Lotemax® (loteprednol etabonate ophthalmic ointment) 0.5%, Lotemax^® (loteprednol etabonate ophthalmic gel) 0.38% and Prolensa^® (bromfenac ophthalmic solution) 0.07%

The company expands the enVista^® family of intraocular lenses with the addition of the enVista^® Toric

Bausch + Lomb acquires Croma and launches EyeCee One preloaded IOL

The company receives Health Canada approval for VYZULTA^® (latanoprostene bunod ophthalmicsolution) 0.024% and Bepreve^® (bepotastine besilate ophthalmic solution) 1.5%

Bausch + Lomb expands its Vision Care portfolio with the addition of Bausch + Lomb ULTRA^® forAstigmatism contact lenses and Biotrue^®ONEday for Astigmatism contact lenses

Bausch + Lomb introduces its next-generation phacoemulsification system, the Stellaris Elite^®vision enhancement system, which offers cataract and retina capabilities in a single platform

FineVision^® MICRO Trifocal IOL is approved, the first trifocal to be approved by Health Canada